glp-1 gastric intestinal obstruction lawsuit in west virginia 🚨 What if the biggest weight-loss trend isn't telling the whole story? Ozempic and other drugs have helped millions manage diabetes and lose weight. But thousands of lawsuits now claim serious Ozempic GLP-1 Gastroparesis Lawsuit |

Mendelsohn lays out why Vivani shifted from a broad platform story to focusing 90% of the company on a GLP-1 drugdevice product, how theyre using the 505(b)(2) pathway to shorten development by leveraging existing semaglutide data, and why the ability to stop treatment by removing the implant addresses a limitation of long-acting injectables

Achieve your weight loss goals with our expert-led medical weight loss programs in Salt Lake City

Investigators found GLP-1s are effective in helping kids and teens manage weight and diabetes, with no increase in serious mental health risks compared with placebo.

The success of these agents in preclinical models and clinical trials suggests a promising future for multiagonists in the treatment of metabolic diseases, with the most recent glucose-dependent insulinotropic peptide receptor:glucagon-like peptide 1 receptor:glucagon receptor (GIPR:GLP-1R:GCGR) triagonists rivaling the efficacy of bariatric surgery

Blocks the kidney protein that pulls glucose back into your blood, helping excrete sugar

As demand for weight-loss treatments increases, some pharmacies have begun offering compounded versions of popular drugs like semaglutide and tirzepatide